As Tylenol Lawsuits Mount, FDA Issues Yet Another Caution Regarding the Potential for Acetaminophen

The Firm is investigating Tylenol lawsuits on behalf of patients who allegedly suffered acetaminophen-induced liver damage due to their use of Tylenol-brand over-the-counter medications. New York, New York (PRWEB) June 10, 2014 As Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has issued yet another caution regarding the potential for acetaminophen, the active ingredient in Tylenol-brand over-the-counter products, to cause liver damage. According to a Consumer Alert
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories